#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophagocytic lymphohistiocytosis Cutaneous calcification Acute myeloid leukaemia recurrent Selective polysaccharide antibody deficiency Congenital disorder of glycosylation Glomerulonephritis minimal lesion Ductal adenocarcinoma of pancreas Infertility female Acute promyelocytic leukaemia Liposarcoma recurrent Scleroderma associated digital ulcer Biliary cancer metastatic Follicular lymphoma stage I Leukodystrophy Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome – Trials in Disease Chondrosarcoma metastatic – Treatment Biotinidase deficiency – Trials in Disease Erdheim-Chester disease – Diagnostics Marfan’s syndrome – Life with Disease Hereditary hypophosphataemic rickets – Life with Disease Arterial tortuosity syndrome – Life with Disease Mucous membrane pemphigoid Breast angiosarcoma metastatic – Trials in Disease Glycogen storage disease type II – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clazakizumab Posenacaftor SAROGLITAZAR HEMIMAGNESIUM Belinostat Bintrafusp Alfa Emedastine Cobimetinib Bhv-7000 Cannabis Sativa Flower ARLOCABTAGENE AUTOLEUCEL Ixazomib Duvakitug Vamorolone Amikacin Spironolactone Bisoprolol Fumarate S-241656 VTX2735 SODIUM Fluticasone Quetiapine More therapies…

    Learn about Your Condition

    Cardiac disorder Erectile dysfunction Adenocarcinoma of colon Chronic myeloid leukaemia Embolism Small intestine adenocarcinoma Nicotine dependence Coronary artery occlusion Post procedural complication Acute myocardial infarction Becker's muscular dystrophy Asthma Diabetic retinopathy Peritoneal sarcoma Plasma cell myeloma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hippokrateslaan 10, Batiment 54, Woluwe-Saint-Lambert, 1200, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Vinblastine Sulfate
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia Finland France Germany +4

  • Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Dexamethasone
    • Methotrexate
    Austria Belgium Czechia Finland France Germany +5

  • Study to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies

    Recruiting

    4 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    Investigated Drugs:
    • Recombinant Human Surfactant Protein-D
    Belgium Czechia France Germany Italy Poland +2

  • Study on the Effectiveness of INM004 for Children with Hemolytic Uremic Syndrome Caused by Shiga Toxin-Producing E. coli

    Recruiting

    3 1
    Investigated Drugs:
    • Equine Immunoglobulin F(Ab’)2 Fragments Targeting Shiga Toxin
    Belgium France Germany Ireland Italy The Netherlands +2

  • Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Bio89-100
    Belgium Bulgaria France Germany Hungary Italy +3

  • Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Czechia Denmark Finland +12

  • Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

    Recruiting

    3 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
    • Clostridia, Cluster Iv, Strain Relative Anaerotruncus Colihominis, Live
    • Clostridia, Cluster Iv, Strain Relative Flavonifractor Plautii, Live
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study Comparing Dostarlimab with CAPEOX and CAPEOX Alone for Patients with Untreated Stage III Colon Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer metastatic
    Investigated Drugs:
    • Capecitabine
    • Dostarlimab
    • Oxaliplatin
    Belgium Italy Spain

  • Study on Doxapram for Treating Apnea in Preterm Newborns

    Recruiting

    3 1
    Investigated Diseases:
    • Infantile apnoea
    Investigated Drugs:
    • Doxapram Hydrochloride Monohydrate
    Belgium The Netherlands

  • Study on Treating Chronic Lymphocytic Leukemia with Venetoclax and Acalabrutinib for Patients Whose Disease Has Returned After Initial Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Venetoclax
    Belgium Denmark The Netherlands
Previous Page
1 … 14 15 16 17 18 … 67
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!